HEALIUS LIMITED — Director's Dealing 2023

Dec 18, 2023

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	HEALIUS LIMITED
ABN	24 064 530 516

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Gordon Richard Davis
Date of last notice	6 September 2023

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct and Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances givingrise to the relevant interest.	As shown
Date of change	14 December 2023
No. of securities held prior tochange	1. 40,214 OrdinaryShares*Gordon Davis2. 55,759 OrdinarySharesGR & G DavisSuperannuation Fund*Shares are subject to a holding lock as “Restricted Shares”under the NED Share Plan.
Class	Ordinary Shares
Number acquired	1. 11,0182. 15,277
Number disposed	N/A
Value/ConsiderationNote: If consideration is non-cash, provide detailsand estimated valuation	$1.20 per Ordinary Share

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

51,232 Ordinary Shares* Gordon Davis GR & G Davis 71,036 Ordinary Shares No. of securities held after Superannuation Fund change * 40,214 Shares are subject to a holding lock as “Restricted Shares” under the NED Share Plan. Acceptance of pro rata offer to acquire securities under Nature of change the Healius Retail Entitlement Offer of its fully Example: on-market trade, off-market trade, exercise of options, issue of securities under underwritten 1 for 3.65 pro-rata accelerated nondividend reinvestment plan, participation in buyrenounceable entitlement offer of new fully paid ordinary back shares as announced on Monday, 20 November 2023.

Part 2 – Change of director’s interests in contracts Not applicable

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a[+] closed period where N/A prior written clearance was required? If so, was prior written clearance provided to allow the N/A trade to proceed during this period? If prior written clearance was provided, on what date N/A was this provided?

Authorised by the Company Secretary.

Mary Weaver Company Secretary Date: 19 December 2023

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011